By Cleveland Clinic –
Patient with quadruple refractory multiple myeloma achieves complete response with cell therapy
A Cleveland Clinic patient participated in a clinical trial of allogenic CAR T-cell therapy to treat highly resistant multiple myeloma and achieved a complete response. Five years later, her remission has endured. “The duration of response is stunning,” says Multiple Myeloma Program Director Jason Valent, MD.
